Abstract library

5 results for "Strecht".
#1469 Theragnostic Approach of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) – The Role of Nuclear Medicine (NM) in a Multidisciplinary Team
Introduction: NET pts are a clinical challenge requiring intervention of multiple medical specialties
Conference: 13th Annual ENETS conference (2016)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Dr Teresa Lucio
Authors: Lucio T, Gaspar C, Cunha C, Roque R, ...
Keywords: PRRT, GEP-NET
#1530 Bizarre Neuroendocrine Tumour Presentations
Introduction: Herein we present two cases of neuroendocrine tumours (NET)with atypical presentations.
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Carolina Palmela
#1866 NET – Incidental Findings: Small, Silent and Innocent?
Introduction: Neuroendocrine tumours (NETs) are rare neoplasms, with an overall incidence of 2 cases per 100,000 individuals per year. This number is increasing due to improved diagnosis, classification and higher imaging sensitivity, which lead to discovering of small and clinically insignificant NETs.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Marisa Peralta Ferreira
Keywords: NET, incidentaloma
#2218 More than Rare Pheochromocytomas: Bilateral and Hemorrhagic, Giant and Metastatic
Introduction: Pheochromocytomas (PCC) are rare neuroendocrine tumors. These catecholamine-secreting tumors, with an average size of 4.9cm, are multiple in 10% of cases. About 10% are malignant but distant metastases are rare. Non-traumatic adrenal hemorrhage is an unusual potentially fatal event seen in PCC.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: Marisa Peralta Ferreira
#2181 Using Adult Stem-Cell Derived Organoids to Model Neuroendocrine Tumor Growth
Introduction: Neuroendocrine tumors (NETs) are a genetically diverse set of rare tumors, which have limited treatment options. The development of more effective therapies for NETs has been limited in part by the absence of in vitro and in vivo models that accurately represent the heterogeneity of these tumors.
Conference: 15th Annual ENETS conference (2018)
Category: Basic Science - In vitro models, tumor growth, CTCs
Presenting Author: PhD Talya Dayton